Abstract
Case Summary
Corneal tattooing operation was performed on three patients (3 cases) with a traumatic iris defect. In case 1, the cornea was dyed with Davidson® marking dyes (Bradley Products Inc., MN, US) and the amniotic membrane with the central incision was permanently transplanted. In case 2, both corneal dyeing and permanent amniotic membrane transplantation were performed on the area of partial iris loss. In case 3, corneal dyeing was performed after the intrastromal cornea was dissected. Corneal reepithelization was found in the first 2 cases 12 and 9 days after amniotic membrane transplantation, respectively. Three months after the transplantation, all three cases showed an improvement in best corrected visual acuity (BCVA), with an increase of one or more lines on the Snellen Chart. Simultaneously, preoperative monocular contrast and glare were also found to beimproved in all three cases. In both cases 1 and 2, 60% of the initially used dyes still remained in the cornea 6 months after the surgery, and in case 3, 90% of the initial dye remained. Except for the moderate astigmatism found earlier after the surgery in case 3, no serious complications developed.
References
3. Milea D, Burillon C. Aniridia in a patient with tuberous sclerosis. Br J Ophthalmol. 1997; 81:804.
5. Choyce P. Intraocular lenses and implants. London: HK Lewis;1964. p. 124–9.
6. Sundmacher R, Reinhard T, Althaus C. Black diaphragm intraocular lens for correction of aniridia. Ger J ophthalmol. 1994; 25:180–5.
7. Suh DS, Roh JH, Kim SD. Clinical experience with black- diaphragm intraocular lens in traumatic (Postoperative) aniridia and aphakia. J Korean Ophthalmol Soc. 1998; 39:1183–91.
8. Reinhard T, Sundmacher R. Black diaphragm aniridia intra-ocular lens for congenital aniridia: Long-term follow-up. J Cataract Refract Surg. 2000; 26:375–81.
9. Lee JJ, Lee SJ, Kim SD. Black diaphragm intraocular lens for traumatic aniridia: Long-term follow-up. J Korean Ophthalmol Soc. 2008; 49:238–44.
10. Remky A, Redbrake C, Wenzel M. Intrastromal corneal tattooing for iris defects. J Cataract Refract Surg. 1998; 24:1285–7.
11. Beekhuis WH, Drost BH, van der Velden/Samderubun EM. A new treatment for photophobia in posttraumatic aniridia: A case report. Cornea. 1998; 17:338–41.
13. Reed JW, Beran RF. Elimination of monocular diplopia by corneal tattooing. Ophthalmic Surg. 1988; 19:437–9.
14. Reed JW. Corneal tattooing to reduce glare in cases of traumatic iris loss. Cornea. 1994; 13:401–5.
15. Leigh AG. Tattooing of the cornea. Duke-Elder S, editor. System of ophthalmology. 1st. London: Henry Kimpton;1965. v. 8. chap. 5.
16. Sekundo W, Seifert P, Seitz B, Loeffler KU. Long term ultrastructural changes in human corneas after tattooing with non-metallic substances. Br J Ophthalmol. 1999; 83:219–24.
17. Olander K, Kanai A, Kaufman HE. An analytical electron microscopic study of a corneal tattoo. Ann Ophthalmol. 1983; 15:1046–9.
18. Wessels IF, Wessels GF. Mechanized keratomicropigmentation: Corneal tattooing with the blepharopigmentor. Ophthalmic Surg Lasers. 1996; 27:25–8.
19. Lee JE, Lee SU, Kim JH. . Corneal tattooing tomask the opacification after amniotic membrane grafting for corneal ulcer. J Korean Ophthalmol Soc. 2006; 47:1491–5.
20. Roper-Hall MJ. The conjunctiva, cornea, and sclera. In: Stallard HB. Stallard’s eye surgery. 7th. Kent: Butterworths;1989. v. 2. chap. 13.
21. Khan AO, Meyer D. Corneal tattooing for the treatment of debilitating glare in a child with traumatic iris loss. Am J Ophthalmol. 2005; 139:920–1.
22. Burris TE, Holmes-Higgin DK, Silvestrini TA. Lamellar intrastromal corneal tattoo for treating iris defects (Artificial iris). Cornea. 1998; 17:169–73.
23. Budavari S. The Merck index-an encyclopedia of chemicals, drugs, and biological. O’Neil MJ. The Merck index. 13th. New Jersey: Merck and Co. Inc.;1996. v. 8. chap. 1.
24. Hathaway GJ, Proctor NH, Hughes JP. Chemical hazards of the workplace. 3rd. Vol. 1. New York: Van Nostrand Reinhold;1991. p. 329–31.
25. Tang CK, Ahn HB, Park WC. The clinical effects of dye-amniotic membrane transplantation on bullous kerato-pathy. J Korean Ophthalmol Soc. 2003; 44:1741–7.
26. Kim YK, Han YK, Wee WR. . 7 Cases of combined corneal tattooing and amniotic membrane transplantation in bullous keratopathy. J Korean Ophthalmol Soc. 2008; 49:503–8.
27. Mejia LF, Santamaria JP, Acosta C. Symptomatic management of postoperative bullous keratopathy with nonpreserved human amniotic membrane. Cornea. 2002; 21:342–5.
28. Espana EM, Grueterich M, Sandoval H. . Amniotic membrane transplantation for bullous keratopathy in eyes with poor visual potential. J Cataract Refract Surg. 2003; 29:279–84.
29. Pires RT, Tseng SC, Kim JC. . Amniotic membrane transplantation for symptomatic bullous keratopathy. Arch Ophthalmol. 1999; 117:1291–7.
30. Hersh PS, Shingleton BJ, Kenyon KR. Anterior segment trauma. Albert DM, Jakobiec FA, editors. Principles and Practice of Ophthalmology. 2nd. Philadelphia: PA Saunders;1994. v. 2. chap. 8.
31. Sundmacher R, Reihnhard T, Althaus C. Black diaphragm intraocular lens in congenital anridia. Ger J Ophthalmol. 1994; 3:197–201.